Ge Liu
P.R. China
Nanjing, 210009, China
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Group 3 Innate Lymphoid Cells (ILC3s): A Promising Immune Cell Group as Therapeutic Targets for Sjögren's Syndrome.
Journal: Current pharmaceutical design
Published: August 26, 2025
Total Glucosides of Paeony (TGP) Inhibits Macrophages Infiltration and NLRP3-Mediated Inflammatory Response in Acute Gouty Arthritis Mice.
Journal: Journal of inflammation research
Published: March 12, 2025
The Progress of Immune Cells-induced Inflammatory Response in Gout.
Journal: Current pharmaceutical design
Published: November 05, 2024
Uric Acid: A Biomarker and Pathogenic Factor of Affective Disorders and Neurodegenerative Diseases.
Journal: Current pharmaceutical design
Published: June 25, 2024
P-Glycoprotein Exacerbates Brain Injury Following Experimental Cerebral Ischemia by Promoting Proinflammatory Microglia Activation.
Journal: Oxidative medicine and cellular longevity
Published: January 18, 2023
Assessment of liver injury using indocyanine green fluorescence imaging.
Journal: Annals of translational medicine
Published: May 25, 2021
Ginkgo diterpene lactones inhibit cerebral ischemia/reperfusion induced inflammatory response in astrocytes via TLR4/NF-κB pathway in rats.
Journal: Journal of ethnopharmacology
Published: September 23, 2019
Significance and Mechanisms of P-glycoprotein in Central Nervous System Diseases.
Journal: Current drug targets
Published: January 25, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026